| 1 |
34064412 | Composites of Nucleic Acids and Boron Clusters (C2B10H12) as Functional Nanoparticles for Downregulation of EGFR Oncogene in Cancer Cells. | 2021 May 4 |
1 |
| 2 |
31925985 | ARL4C is associated with initiation and progression of lung adenocarcinoma and represents a therapeutic target. | 2020 Mar |
2 |
| 3 |
31164704 | Sensitive detection of low-abundance in-frame deletions in EGFR exon 19 using novel wild-type blockers in real-time PCR. | 2019 Jun 4 |
1 |
| 4 |
29514240 | Cellular uptake mediated by epidermal growth factor receptor facilitates the intracellular activity of phosphorothioate-modified antisense oligonucleotides. | 2018 Apr 20 |
1 |
| 5 |
29748615 | Specific targeting of point mutations in EGFR L858R-positive lung cancer by CRISPR/Cas9. | 2018 Jul |
1 |
| 6 |
28272528 | EGFR induces DNA decomposition via phosphodiester bond cleavage. | 2017 Mar 8 |
1 |
| 7 |
28425453 | Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers. | 2017 Apr 20 |
1 |
| 8 |
28832537 | High Boron-loaded DNA-Oligomers as Potential Boron Neutron Capture Therapy and Antisense Oligonucleotide Dual-Action Anticancer Agents. | 2017 Aug 23 |
2 |
| 9 |
28881435 | Versatile Method for the Site-Specific Modification of DNA with Boron Clusters: Anti-Epidermal Growth Factor Receptor (EGFR) Antisense Oligonucleotide Case. | 2017 Nov 21 |
2 |
| 10 |
23103856 | Oncogenic and wild-type Ras play divergent roles in the regulation of mitogen-activated protein kinase signaling. | 2013 Jan |
1 |
| 11 |
23395887 | Downregulation of HER3 by a novel antisense oligonucleotide, EZN-3920, improves the antitumor activity of EGFR and HER2 tyrosine kinase inhibitors in animal models. | 2013 Apr |
1 |
| 12 |
23534780 | EGFR antisense oligonucleotides encapsulated with nanoparticles decrease EGFR, MAPK1 and STAT5 expression in a human colon cancer cell line. | 2013 |
3 |
| 13 |
23571736 | Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis. | 2013 Apr 30 |
2 |
| 14 |
23953842 | Epidermal growth factor receptor targeting in cancer: a review of trends and strategies. | 2013 Nov |
1 |
| 15 |
21573974 | Differentiated prostatic antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against BCL-2 and EGFR. | 2012 Jun |
1 |
| 16 |
21325655 | Biotinylated probe isolation of targeted gene region improves detection of T790M epidermal growth factor receptor mutation via peptide nucleic acid-enriched real-time PCR. | 2011 May |
1 |
| 17 |
21756831 | [Comparison of real-time quantitative PCR and allele-specific oligonucleotide PCR for detections of L858R mutation in epidermal growth factor receptor gene exon 21]. | 2011 May |
1 |
| 18 |
21890455 | Toll-like receptor 9 agonist IMO cooperates with cetuximab in K-ras mutant colorectal and pancreatic cancers. | 2011 Oct 15 |
2 |
| 19 |
22321542 | [Epidermal growth factor receptor gene mutations and clinicopathologic correlation in 309 patients with non-small cell lung cancer]. | 2011 Oct |
2 |
| 20 |
19937163 | Increased prostate-specific membrane antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against bcl-2 and EGFR. | 2010 Dec |
1 |
| 21 |
19347870 | Down-regulation of epidermal growth factor receptor induced by estrogens and phytoestrogens promotes the differentiation of U2OS human osteosarcoma cells. | 2009 Jul |
1 |
| 22 |
19766894 | Epidermal growth factor promotes epidermal growth factor receptor nuclear accumulation by a pathway dependent on cytoskeleton integrity in human breast cancer cells. | 2009 Jul |
1 |
| 23 |
19836242 | An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis. | 2009 Nov 17 |
1 |
| 24 |
19903791 | A novel toll-like receptor 9 agonist cooperates with trastuzumab in trastuzumab-resistant breast tumors through multiple mechanisms of action. | 2009 Nov 15 |
3 |
| 25 |
17972023 | Treatment of MCF-7 breast cancer cells employing mono- and bispecific antisense oligonucleotides having binding specificity toward proteins associated with autocrine regulated growth and BCL-2. | 2008 |
3 |
| 26 |
18025070 | Antitumor mechanisms of systemically administered epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck. | 2008 Mar |
7 |
| 27 |
18207161 | Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule. | 2008 Mar 7 |
1 |
| 28 |
17636117 | TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts. | 2007 Jul 24 |
3 |
| 29 |
17848743 | Bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors. | 2007 |
3 |
| 30 |
17917084 | Combination chemotherapy employing bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors. | 2007 |
2 |
| 31 |
17922545 | Oligonucleotide-coated metallic nanoparticles as a flexible platform for molecular imaging agents. | 2007 Nov-Dec |
1 |
| 32 |
16597093 | Targeting the epidermal growth factor receptor (EGFR)--a new therapeutic option in oncology? | 2006 Jan 7 |
1 |
| 33 |
16870352 | Synthesis of branched antisense oligonucleotides having multiple specificities. Treatment of hormone insensitive prostate cancer. | 2006 |
4 |
| 34 |
17136230 | Bispecific antisense oligonucleotides with multiple binding sites for the treatment of prostate tumors and their applicability to combination therapy. | 2006 Oct |
4 |
| 35 |
15720189 | Chemosensitization by antisense oligonucleotides targeting MDM2. | 2005 Feb |
2 |
| 36 |
16075456 | Analysis of the epidermal growth factor receptor specific transcriptome: effect of receptor expression level and an activating mutation. | 2005 Oct 1 |
1 |
| 37 |
14688027 | Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R). | 2004 Apr |
1 |
| 38 |
15599851 | The epidermal growth factor receptor signaling network in head and neck carcinogenesis and implications for targeted therapy. | 2004 Dec |
2 |
| 39 |
12665682 | Inhibition of PC-3 prostate cancer cell growth in vitro using both antisense oligonucleotides and taxol. | 2003 |
4 |
| 40 |
12948863 | Messenger RNA expression profiling of genes involved in epidermal growth factor receptor signalling in human cancer cells treated with scanning array-designed antisense oligonucleotides. | 2003 Sep 1 |
1 |
| 41 |
14763145 | [Therapeutic implications of epidermal growth factor receptor in lung cancer]. | 2003 Nov |
1 |
| 42 |
11830539 | Early Growth Response-1 gene mediates up-regulation of epidermal growth factor receptor expression during hypoxia. | 2002 Feb 1 |
2 |
| 43 |
12063543 | EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration. | 2002 Jul |
2 |
| 44 |
12119273 | Protein kinase A as target for novel integrated strategies of cancer therapy. | 2002 Jun |
1 |
| 45 |
12616956 | Backbone modification alters the efficacy of antisense oligonucleotides directed against mRNA encoding either TGF-alpha or EGFR in the treatment of prostate cancer cell lines. | 2002 Dec |
3 |
| 46 |
11278982 | c-Jun N-terminal kinase activation by hydrogen peroxide in endothelial cells involves SRC-dependent epidermal growth factor receptor transactivation. | 2001 May 11 |
3 |
| 47 |
11410862 | Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines. | 2001 Jul 15 |
8 |
| 48 |
11484948 | The type III epidermal growth factor receptor mutation. Biological significance and potential target for anti-cancer therapy. | 2001 Jun |
1 |
| 49 |
11778757 | Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding transforming growth factor-alpha and the epidermal growth factor receptor. | 2001 |
5 |
| 50 |
10206071 | Antisense oligonucleotides to the epidermal growth factor receptor. | 1999 Jan |
5 |